Propionic Acid

Propionic Acid

SCHEMBL4160658

CCC(=O)O.CNS(=O)(=O)c1ccc2[nH]c(=O)c3[nH]ccc3c2c1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 1/20 0.49
KDM4E B2RXH2 3/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
PARP1 P09874 4/20 0.41
BRAF P15056 4/20 0.41
BAZ2B Q9UIF8 1/20 0.41
HTR7 P34969 1/20 0.40
HTR5A P47898 1/20 0.40
HTR6 P50406 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
PARG Q86W56 1/20 0.38
BRD4 O60885 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4155193 0.87 RXFP1 (0.41) KDM4EGRIN2DGRIN3BALDH1A1GRIN1
Propionic Acid SCHEMBL4163285 0.87 PKM (0.54) PARP1BRAFBRD4PKM
Propionic Acid SCHEMBL4153577 0.86 PARG (0.57) TAS2R14KDM4EGRIN2DGRIN3BALDH1A1
Propionic Acid SCHEMBL4162918 0.86 BRAF (0.46) KDM4EBRAFBAZ2BRXFP1
Propionic Acid SCHEMBL4157631 0.86 BRAF (0.54) ALDH1A1BRAFPKMMAPK1
Propionic Acid SCHEMBL4153953 0.86 PKM (0.55) ALDH1A1BRAFBRD4PKMMAPK1
Propionic Acid SCHEMBL4160232 0.85 BRD4 (0.51) BRAFBRD4PKM
Propionic Acid SCHEMBL4161141 0.85 BRAF (0.53) BRAFBRD4PKM
Propionic Acid SCHEMBL4162959 0.85 BRAF (0.46) ALDH1A1BRAFHTR6BRD4PKM
Propionic Acid SCHEMBL4157652 0.85 TDP1 (0.56) TAS2R14ALDH1A1BRAFPARGPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 TAS2R14 4728/4885KDM4E 1970/4885GRIN2D 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.